Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02081794 · ClinicalTrials.gov registry record · NA

Tailoring Patient Education to Perceived Risk for Falls in Hospitalized Oncology Patients

A NA study of Malignant Neoplasm, sponsored by Case Comprehensive Cancer Center.

Completed
Registry status
NA
Development phase
91
Enrollment target
1
Study location

NCT02081794 is a NA study of Malignant Neoplasm that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 91 participants, below the 512-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02081794, a NA study of Malignant Neoplasm, has completed, sponsored by Case Comprehensive Cancer Center.

COMPLETED
Registry status
NA
Development phase
91 participants
Enrollment target
1
Study location

Study Summary

This randomized pilot clinical trial studies tailored patient educational intervention or standard education in assessing perceived risk for falls in hospitalized oncology patients. A tailored patient educational intervention may be more beneficial than standard education in preventing patients from falling by increasing the patient's knowledge of the risk factors for falling routinely and then providing education in deficit areas. Making patients more aware of the risk factors for falling may lead to greater engagement in preventative activities.

Conditions Studied

Interventions

  • OTHER Tailored education intervention
  • OTHER Standard fall care

Study Locations (1)

Ohio

  • Seidman Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center - Cleveland

Trial Details

FieldValue
Enrollment Target 91 participants
Start Date 2014-02
Est. Completion 2015-09
Phase NA

Sponsor

Case Comprehensive Cancer Center

407 total trials

What the Registry Record Tells You About NCT02081794

The ClinicalTrials.gov registry entry for NCT02081794 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 512-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (82% lower). The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Malignant Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Tailored education intervention is the first listed.

NCT02081794 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT02081794 about?

NCT02081794 is a clinical study titled "Tailoring Patient Education to Perceived Risk for Falls in Hospitalized Oncology Patients". This randomized pilot clinical trial studies tailored patient educational intervention or standard education in assessing perceived risk for falls in hospitalized oncology patients. A tailored patient educational intervention may be more beneficial than standard education in preventing patients from...

What is the current status of trial NCT02081794?

This trial is currently completed. It is a NA study. The enrollment target is 91 participants. The study started on 2014-02. Estimated completion is 2015-09.

What conditions does trial NCT02081794 study?

This clinical trial studies the following conditions: Malignant Neoplasm.

What interventions are being tested in trial NCT02081794?

The interventions under investigation include: Tailored education intervention (OTHER), Standard fall care (OTHER).

Who is sponsoring clinical trial NCT02081794?

This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02081794 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Malignant Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.